Currently, antibody drugs cover not only malignant neoplasms but also autoimmune diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus; allergic diseases such as bronchial asthma; inflammatory bowel diseases (IBD); neurological diseases; and osteoporosis: their effectiveness in these disorders have been investigated and reported.